Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-19

Clinical Trial Update: Effect of Preemptive Intramuscular Diclofenac on Minimal Effective-Dose Bupivacaine Saddle Block for Minor Perianal Surgeries [Phase 2]

View source ↗

Summary

Phase 2 trial update examining preemptive intramuscular diclofenac to optimize minimal effective-dose bupivacaine saddle block for minor perianal surgeries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • Diclofenac (diclofenac)

Snippet

Sponsor: Imam Abdulrahman Bin Faisal University | Conditions: Postoperative Pain | Phase 2 | Status: UNKNOWN